A detailed history of Investors Research Corp transactions in Medtronic PLC stock. As of the latest transaction made, Investors Research Corp holds 14,044 shares of MDT stock, worth $1.24 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
14,044
Previous 14,044 -0.0%
Holding current value
$1.24 Million
Previous $1.22 Million 9.65%
% of portfolio
0.26%
Previous 0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$82.84 - $88.09 $207,100 - $220,225
2,500 Added 21.66%
14,044 $1.22 Million
Q4 2023

Jan 30, 2024

SELL
$69.43 - $83.43 $195,792 - $235,272
-2,820 Reduced 19.63%
11,544 $950,000
Q3 2023

Nov 01, 2023

BUY
$78.22 - $90.4 $3,207 - $3,706
41 Added 0.29%
14,364 $1.13 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $7,947 - $9,138
-100 Reduced 0.69%
14,323 $1.26 Million
Q1 2023

May 11, 2023

BUY
$76.72 - $87.58 $203,461 - $232,262
2,652 Added 22.53%
14,423 $1.16 Million
Q4 2022

Feb 06, 2023

SELL
$76.18 - $87.74 $26,434 - $30,445
-347 Reduced 2.86%
11,771 $914,000
Q3 2022

Nov 10, 2022

BUY
$80.75 - $95.31 $98,918 - $116,754
1,225 Added 11.25%
12,118 $979,000
Q2 2022

Jul 21, 2022

BUY
$87.4 - $113.09 $34,960 - $45,236
400 Added 3.81%
10,893 $978,000
Q1 2022

Apr 13, 2022

BUY
$100.58 - $112.38 $951,889 - $1.06 Million
9,464 Added 919.73%
10,493 $1.16 Million
Q3 2021

Oct 27, 2021

SELL
$122.75 - $135.17 $613 - $675
-5 Reduced 0.48%
1,029 $129,000
Q4 2020

Jan 21, 2021

BUY
$100.57 - $117.14 $502 - $585
5 Added 0.49%
1,034 $121,000
Q1 2020

May 05, 2020

BUY
$72.92 - $121.3 $729 - $1,213
10 Added 0.98%
1,029 $93,000
Q3 2019

Oct 22, 2019

BUY
$98.02 - $111.18 $11,664 - $13,230
119 Added 13.22%
1,019 $111,000
Q1 2019

Apr 23, 2019

BUY
$82.45 - $93.79 $74,205 - $84,411
900 New
900 $82,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $117B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.